Targeting drugs to mitochondria

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 82, Issue 1, 2012, Pages 1-18

  Heller, Anne ^a   Brockhoff, Gero ^a   Goepferich, Achim ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Drug delivery; Intracellular targeting; Mitochondria; Mitochondrial diseases; Nanocarriers; Targeting strategies

Indexed keywords

ALPHA TOCOPHEROL; ANTHRACYCLINE DERIVATIVE; ANTIOXIDANT; ARSENIC TRIOXIDE; BENZOTHIAZEPINE DERIVATIVE; BETA LAPACHONE; BETULIC ACID; BUTHIONINE SULFOXIMINE; CERAMIDE DERIVATIVE; CIPROFLOXACIN; CISPLATIN; CYCLOSPORIN A; DIAZEPAM DERIVATIVE; DIAZOXIDE; DICHLOROACETIC ACID; DOXORUBICIN; ESTROGEN DERIVATIVE; GADOLINIUM TEXAPHYRIN; IMEXON; LONIDAMINE; MANGAFODIPIR; MENADIONE; NONSTEROID ANTIINFLAMMATORY AGENT; NUCLEOSIDE DERIVATIVE; PACLITAXEL; PARTHENOLIDE; RESVERATROL; UBIDECARENONE; UNINDEXED DRUG; ZIDOVUDINE;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIOXIDANT ACTIVITY; CELL FUNCTION; CELL ULTRASTRUCTURE; CELL VIABILITY; CHEMICAL MODIFICATION; CYTOSOL; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG DELIVERY SYSTEM; DRUG SPECIFICITY; DRUG TARGETING; HUMAN; INTRACELLULAR SIGNALING; INTRACELLULAR TRANSPORT; MITOCHONDRION; MOLECULARLY TARGETED THERAPY; NANOENCAPSULATION; OXIDATIVE STRESS; PROTEIN LOCALIZATION; PROTEIN TARGETING; REVIEW; TARGET CELL;

DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG DESIGN; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DISEASES; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS;

EID: 84866031913     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.05.014     Document Type: Review

References (143)

1. P.J. Hollenbeck, and W. Saxton The axonal transport of mitochondria J. Cell Sci. 118 2005 5411 5419
2. I. Manoli, S. Alesci, and G. Chrousos Mitochondria G. Fink, Encyclopedia of Stress second ed. 2007 Academic Press San Diego 754 761
3. P.F. Chinnery, and E.A. Schon Mitochondria J. Neurol. Neurosurg. Psychiatry 74 2003 1188 1199
4. J.S. Modica-Napolitano, and K.K. Singh Mitochondrial dysfunction in cancer Mitochondrion 4 2004 755 762
5. M.-C. Frantz, and P. Wipf Mitochondria as a target in treatment Environ. Mol. Mutagen 51 2010 462 475
6. S. Fulda, L. Galluzzi, and G. Kroemer Targeting mitochondria for cancer therapy Nat. Rev. Drug Discov. 9 2010 447 464
7. R.A.J. Smith, and M.P. Murphy Mitochondria-targeted antioxidants as therapies Discov. Med. 11 2011 106 114
8. S. Moghimi, A. Hunter, and T. Andresen Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective Annu. Rev. Pharmacol. Toxicol. 52 2012 481 503
9. G.G. D'Souza, M.A. Wagle, V. Saxena, and A. Shah Approaches for targeting mitochondria in cancer therapy Biochim. Biophys. Acta (BBA) - Bioenergetics 1807 2011 689 696
10. V.J. Stella, W.N. Charman, and V.H. Naringrekar Prodrugs. Do they have advantages in clinical practice? Drugs 29 1985 455 473
11. J.H. Lin, and A.Y. Lu Role of pharmacokinetics and metabolism in drug discovery and development Pharmacol. Rev. 49 1997 403 449
12. H. Ringsdorf Structure and properties of pharmacologically active polymers J. Polym. Sci., C Polym. Symp. 51 1975 135 153
13. M.L. Immordino, F. Dosio, and L. Cattel Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int. J. Nanomed. 1 2006 297 315
14. V.P. Torchilin Recent approaches to intracellular delivery of drugs and DNA and organelle targeting Annu. Rev. Biomed. Eng. 8 2006 343 375
15. E. Blanco, A. Hsiao, A.P. Mann, M.G. Landry, F. Meric-Bernstam, and M. Ferrari Nanomedicine in cancer therapy: innovative trends and prospects Cancer Sci. 102 2011 1247 1252
16. D.R. Lewis, K. Kamisoglu, A.W. York, and P.V. Moghe Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis WIREs Nanomed. Nanobiotechnol. 3 2011 400 420
17. G.G.M. D'Souza, and V. Weissig Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet Expert Opin. Drug Deliv. 6 2009 1135 1148
18. G.G.M. D'Souza, S.V. Boddapati, and V. Weissig Gene therapy of the other genome: the challenges of treating mitochondrial DNA defects Pharm. Res. 24 2007 228 238
19. K. Cho, X. Wang, S. Nie, Z. Chen, and D.M. Shin Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 14 2008 1310 1316
20. A.Z. Wang, F. Gu, L. Zhang, J.M. Chan, A. Radovic-Moreno, M.R. Shaikh, and O.C. Farokhzad Biofunctionalized targeted nanoparticles for therapeutic applications Expert Opin. Biol. Ther. 8 2008 1063 1070
21. E. Voltz, and H. Gronemeyer A new era of cancer therapy: cancer cell targeted therapies are coming of age Int. J. Biochem. Cell Biol. 40 2008 1 8
22. F. Mangialasche, A. Solomon, B. Winblad, P. Mecocci, and M. Kivipelto Alzheimer's disease: clinical trials and drug development Lancet Neurol. 9 2010 702 716
23. A. Sosnik, Á.M. Carcaboso, R.J. Glisoni, M.A. Moretton, and D.A. Chiappetta New old challenges in tuberculosis: potentially effective nanotechnologies in drug delivery Adv. Drug Deliv. Rev. 62 2010 547 559
24. J. Sun, Z. Lin, J. Feng, Y. Li, and B. Shen BAFF-targeting therapy, a promising strategy for treating autoimmune diseases Eur. J. Pharmacol. 597 2008 1 5
25. S. Kunjachan, S. Gupta, A.K. Dwivedi, A. Dube, and M.K. Chourasia Chitosan-based macrophage-mediated drug targeting for the treatment of experimental visceral leishmaniasis J. Microencapsul. 28 2011 301 310
26. V.P. Torchilin, Passive and active drug targeting: drug delivery to tumors as an example, in: M. Schäfer-Korting (Ed.), Drug Delivery, 2010, pp. 3-53.
27. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760
28. S.A. Kularatne, and P.S. Low Targeting of nanoparticles: folate receptor S.R. Grobmyer, B.M. Moudgil, Methods in Molecular Biology 2010 Humana Press Totowa, NJ 249 265
29. P. Kocbek, N. Obermajer, M. Cegnar, J. Kos, and J. Kristl Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody J. Control. Release 120 2007 18 26
30. Y. Teow, and S. Valiyaveettil Active targeting of cancer cells using folic acid-conjugated platinum nanoparticles Nanoscale 2 2010 2607
31. J. You, X. Li, F. de Cui, Y.-Z. Du, H. Yuan, and F.q. Hu Folate-conjugated polymer micelles for active targeting to cancer cells: preparation, in vitro evaluation of targeting ability and cytotoxicity Nanotechnology 19 2008 45102
32. M. Talekar, J. Kendall, W. Denny, and S. Garg Targeting of nanoparticles in cancer Anticancer Drugs 22 2011 949 962
33. F. Pene, E. Courtine, A. Cariou, and J.-P. Mira Toward theragnostics Crit. Care Med. 37 2009 S50 58
34. V.H.J. van der Velden, J.G. te Marvelde, P.G. Hoogeveen, I.D. Bernstein, A.B. Houtsmuller, M.S. Berger, and J.J.M. van Dongen Targeting of the CD33-calicheamicin immunoconjugate Mylotarg (CMA-676) in acute myeloid leukemia: in vivo and in vitro saturation and internalization by leukemic and normal myeloid cells Blood 97 2001 3197 3204
35. C. Rousselle, P. Clair, J.M. Lefauconnier, M. Kaczorek, J.M. Scherrmann, and J. Temsamani New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy Mol. Pharmacol. 57 2000 679 686
36. J.C.W. Edwards, L. Szczepanski, J. Szechinski, A. Filipowicz-Sosnowska, P. Emery, D.R. Close, R.M. Stevens, and T. Shaw Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis N. Engl. J. Med. 350 2004 2572 2581
37. P. Kan, C.-W. Tsao, A.-J. Wang, W.-C. Su, and H.-F. Liang A liposomal formulation able to incorporate a high content of paclitaxel and exert promising anticancer effect J. Drug Deliv. 2011 2011 1 9
38. S. Martins, B. Sarmento, D.C. Ferreira, and E.B. Souto Lipid-based colloidal carriers for peptide and protein delivery - liposomes versus lipid nanoparticles Int. J. Nanomed. 2 2007 595 607
39. D.J. Bharali, I. Klejbor, E.K. Stachowiak, P. Dutta, I. Roy, N. Kaur, E.J. Bergey, P.N. Prasad, and M.K. Stachowiak Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain Proc. Nat. Acad. Sci. 102 2005 11539 11544
40. Y. Patil, and J. Panyam Polymeric nanoparticles for siRNA delivery and gene silencing Int. J. Pharm. 367 2009 195 203
41. Y. Yamada, H. Akita, K. Kogure, H. Kamiya, and H. Harashima Mitochondrial drug delivery and mitochondrial disease therapy - an approach to liposome-based delivery targeted to mitochondria Mitochondrion 7 2007 63 71
42. J. Ding, F. Shi, C. Xiao, L. Lin, L. Chen, C. He, X. Zhuang, and X. Chen One-step preparation of reduction-responsive poly(ethylene glycol)-poly(amino acid)s nanogels as efficient intracellular drug delivery platforms Polym. Chem. 2 2011 2857 2864
43. J. das Neves, J. Michiels, K.K. Ariën, G. Vanham, M. Amiji, M.F. Bahia, B. Sarmento, Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine, Pharm. Res. (2011), http://www.ncbi.nlm.nih.gov/pubmed/22072053.
44. P. Costantini, E. Jacotot, D. Decaudin, and G. Kroemer Mitochondrion as a novel target of anticancer chemotherapy J. Natl. Cancer Inst. 92 2000 1042 1053
45. S.W. Lowe, and A.W. Lin Apoptosis in cancer Carcinogenesis 21 2000 485 495
46. V. Weissig, and G.G.M. D'Souza Organelle-specific Pharmaceutical Nanotechnology 2010 Wiley Hoboken, NJ
47. H. Sneh-Edri, D. Likhtenshtein, and D. Stepensky Intracellular targeting of PLGA nanoparticles encapsulating antigenic peptide to the endoplasmic reticulum of dendritic cells and its effect on antigen cross-presentation in vitro Mol. Pharm. 8 2011 1266 1275
48. D. Stepensky Quantitative aspects of intracellularly-targeted drug delivery Pharm. Res. 27 2010 2776 2780
49. S. Fleischer, G. Rouser, B. Fleischer, A. Casu, and G. Kritchevsky Lipid composition of mitochondria from bovine heart, liver, and kidney J. Lipid Res. 8 1967 170 180
50. S.A. Detmer, and D.C. Chan Functions and dysfunctions of mitochondrial dynamics Nat. Rev. Mol. Cell Biol. 8 2007 870 879
51. L.B. Chen Mitochondrial membrane potential in living cells Annu. Rev. Cell Biol. 4 1988 155 181
52. J.-Y. Huang, M.D. Hirschey, T. Shimazu, L. Ho, and E. Verdin Mitochondrial sirtuins Biochim. Biophys. Acta (BBA) - Proteins Proteom. 1804 2010 1645 1651
53. M.W. Gray, and W.F. Doolittle Has the endosymbiont hypothesis been proven? Microbiol. Rev. 46 1982 1 42
54. J.S. Modica-Napolitano, and K.K. Singh Mitochondria as targets for detection and treatment of cancer Expert Rev. Mol. Med. 4 2002 1 19
55. Invitrogen - Molecular Probes - The Handbook, Probes for Mitochondria - Section 12.2, .
56. V. Weissig Mitochondrial-targeted drug and DNA delivery Crit. Rev. Ther. Drug Carrier Syst. 20 2003 1 62
57. S. DiMauro, and E.A. Schon Mitochondrial DNA mutations in human disease Am. J. Med. Genet. 106 2001 18 26
58. F. Hartl, N. Pfanner, D.W. Nicholson, and W. Neupert Mitochondrial protein import Biochim. Biophys. Acta (BBA) - Rev. Biomembr. 988 1989 1 45
59. B.V. Chernyak, O.Y. Pletjushkina, D.S. Izyumov, K.G. Lyamzaev, and A.V. Avetisyan Bioenergetics and death Biochemistry (Moscow) 70 2005 240 245
60. I.R. Boldogh, and L.A. Pon Mitochondria on the move Trends Cell Biol. 17 2007 502 510
61. D.C. Chan Mitochondrial fusion and fission in mammals Annu. Rev. Cell Dev. Biol. 22 2006 79 99
62. H. Chen, M. Vermulst, Y.E. Wang, A. Chomyn, T.A. Prolla, J.M. McCaffery, and D.C. Chan Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations Cell 141 2010 280 289
63. M.B. de Moura, L.S. dos Santos, and B. van Houten Mitochondrial dysfunction in neurodegenerative diseases and cancer Environ. Mol. Mutagen 51 2010 391 405
64. C. Chinopoulos, and V. Adam-Vizi Calcium, mitochondria and oxidative stress in neuronal pathology: novel aspects of an enduring theme FEBS J. 273 2006 433 450
65. D. Harman Aging: a theory based on free radical and radiation chemistry J. Gerontol. 11 1956 298 300
66. V.J. Thannickal, and B.L. Fanburg Reactive oxygen species in cell signaling Am. J. Physiol. Lung Cell Mol. Physiol. 279 2000 L1005 L1028
67. N. Pfanner, and M. Meijer Mitochondrial biogenesis: the Tom and Tim machine Curr. Biol. 7 1997 R100 R103
68. P.F. Chinnery Searching for nuclear-mitochondrial genes Trends Genet. 19 2003 60 62
69. N. Pfanner, and A. Geissler Versatility of the mitochondrial protein import machinery Nat. Rev. Mol. Cell Biol. 2 2001 339 349
70. V. Weissig, and V.P. Torchilin Towards mitochondrial gene therapy: DQAsomes as a strategy J. Drug Target 9 2001 1 13
71. J.S. Carew, Y. Zhou, M. Albitar, J.D. Carew, M.J. Keating, and P. Huang Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications Leukemia 17 2003 1437 1447
72. P.F. Chinnery, N. Howell, R.N. Lightowlers, and D.M. Turnbull MELAS and MERRF. The relationship between maternal mutation load and the frequency of clinically affected offspring Brain 121 Pt 10 1998 1889 1894
73. S. DiMauro Mitochondrial diseases Biochim. Biophys. Acta (BBA) - Bioenergetics 1658 2004 80 88
74. X. Li, and N. Kazgan Mammalian sirtuins and energy metabolism Int. J. Biol. Sci. 7 2011 575 587
75. M.C. Haigis, and L.P. Guarente Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction Genes Dev. 20 2006 2913 2921
76. Y. Tsujimoto Apoptosis and necrosis: intracellular ATP level as a determinant for cell death modes Cell Death Differ. 4 1997 429 434
77. J. Santo-Domingo, and N. Demaurex Calcium uptake mechanisms of mitochondria Biochim. Biophys. Acta (BBA) - Bioenergetics 1797 2010 907 912
78. P.F. Chinnery, Gene Reviews: Mitochondrial Disorders Overview. Mitochondrial Encephalomyopathies, Mitochondrial Myopathies, Oxidative Phosphorylation Disorders, Respiratory Chain Disorders, .
79. D.C. Wallace Mitochondrial diseases in man and mouse Science 283 1999 1482 1488
80. I.J. Holt, A.E. Harding, R.K. Petty, and J.A. Morgan-Hughes A new mitochondrial disease associated with mitochondrial DNA heteroplasmy Am. J. Hum. Genet. 46 1990 428 433
81. J.A. Mayr, T.B. Haack, E. Graf, F.A. Zimmermann, T. Wieland, B. Haberberger, A. Superti-Furga, J. Kirschner, B. Steinmann, M.R. Baumgartner, I. Moroni, E. Lamantea, M. Zeviani, R.J. Rodenburg, J. Smeitink, T.M. Strom, T. Meitinger, W. Sperl, and H. Prokisch Lack of the mitochondrial protein acylglycerol kinase causes Sengers syndrome Am. J. Human Genet. 90 2012 314 320
82. X. Wang, B. Su, H.-g. Lee, X. Li, G. Perry, M.A. Smith, and X. Zhu Impaired balance of mitochondrial fission and fusion in Alzheimer's disease J. Neurosci. 29 2009 9090 9103
83. J.E. Selfridge, E. Lezi, J. Lu, R.H. Swerdlow, Role of Mitochondrial Homeostasis and Dynamics in Alzheimer's disease, .
84. S. DiMauro, K. Tanji, E. Bonilla, F. Pallotti, and E.A. Schon Mitochondrial abnormalities in muscle and other aging cells: classification, causes, and effects Muscle Nerve 26 2002 597 607
85. J.N. Keller, G.W. Glazner, Mitochondrial oxidative stress and metabolic alterations in neurodegenerative disorders, in: M.P. Mattson (Ed.), Advances in Cell Aging and Gerontology: Interorganelle Signaling in Age-Related diseases, 2001, pp. 205-237.
86. P.F. Chinnery, and D.M. Turnbull Mitochondrial DNA mutations in the pathogenesis of human disease Mol. Med. Today 6 2000 425 432
87. J.S. Armstrong Mitochondria: a target for cancer therapy Br. J. Pharmacol. 147 2006 239 248
88. S. Kasibhatla, and B. Tseng Why target apoptosis in cancer treatment? Mol. Cancer Ther. 2 2003 573 580
89. V. Weissig From serendipity to mitochondria-targeted nanocarriers Pharm. Res. 28 2011 2657 2668
90. E. Holmuhamedov, L. Lewis, M. Bienengraeber, M. Holmuhamedova, A. Jahangir, and A. Terzic Suppression of human tumor cell proliferation through mitochondrial targeting FASEB J. 16 2002 1010 1016
91. D. Morin, T. Hauet, M. Spedding, and J.-P. Tillement Mitochondria as target for antiischemic drugs Adv. Drug Deliv. Rev. 49 2001 151 174
92. M. Lagouge, C. Argmann, Z. Gerhart-Hines, H. Meziane, C. Lerin, F. Daussin, N. Messadeq, J. Milne, P. Lambert, P. Elliott, B. Geny, M. Laakso, P. Puigserver, and J. Auwerx Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α Cell 127 2006 1109 1122
93. E.A. Schon, S. DiMauro, M. Hirano, and R.W. Gilkerson Therapeutic prospects for mitochondrial disease Trends Mol. Med. 16 2010 268 276
94. Santhera Pharmaceuticals Holding AG, Santhera's Marketing Authorization Application for Idebenone in LHON Accepted for Review by European Medicines Agency, 2011, .
95. S.J. Ralph, and J. Neuzil Mitochondria as targets for cancer therapy Mol. Nutr. Food Res. 53 2009 9 28
96. L. Rajendran, H.-J. Knölker, and K. Simons Subcellular targeting strategies for drug design and delivery Nat. Rev. Drug Discov. 9 2010 29 42
97. T.C. Stover, A. Sharma, G.P. Robertson, and M. Kester Systemic delivery of liposomal short-chain ceramide limits solid tumor growth in murine models of breast adenocarcinoma Clin. Cancer Res. 11 2005 3465 3474
98. S.V. Boddapati, G.G.M. D'Souza, S. Erdogan, V.P. Torchilin, and V. Weissig Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo Nano Lett. 8 2008 2559 2563
99. M.P. Mattson, and G. Kroemer Mitochondria in cell death: novel targets for neuroprotection and cardioprotection Trends Mol. Med. 9 2003 196 205
100. J. Morgan, and A.R. Oseroff Mitochondria-based photodynamic anti-cancer therapy Adv. Drug Deliv. Rev. 49 2001 71 86
101. H.H. Szeto Mitochondria-targeted peptide antioxidants: novel neuroprotective agents AAPS J. 8 2006 E277 E283
102. K. Zhao, G.-M. Zhao, D. Wu, Y. Soong, A.V. Birk, P.W. Schiller, and H.H. Szeto Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury J. Biol. Chem. 279 2004 34682 34690
103. E. Gnaiger, Isolated Mitochondria or Permeabilized Tissues and Cells, .
104. Y. Yamada, and H. Harashima Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases Adv. Drug Deliv. Rev. 60 2008 1439 1462
105. M. Duvvuri, W. Feng, A. Mathis, and J.P. Krise A cell fractionation approach for the quantitative analysis of subcellular drug disposition Pharm. Res. 21 2004 26 32
106. K.M. Fuller, and E.A. Arriaga Advances in the analysis of single mitochondria Curr. Opin. Biotechnol. 14 2003 35 41
107. M.D. Brand, and D.G. Nicholls Assessing mitochondrial dysfunction in cells Biochem. J. 435 2011 297 312
108. C. Frezza, S. Cipolat, and L. Scorrano Organelle isolation: functional mitochondria from mouse liver, muscle and cultured filroblasts Nat. Protoc. 2 2007 287 295
109. E. Fernández-Vizarra, G. Ferrín, A. Pérez-Martos, P. Fernández-Silva, M. Zeviani, and J.A. Enríquez Isolation of mitochondria for biogenetical studies: an update Mitochondrion 10 2010 253 262
110. N.R. Sims, and M.F. Anderson Isolation of mitochondria from rat brain using Percoll density gradient centrifugation Nat. Protoc. 3 2008 1228 1239
111. H.-T. Hornig-Do, G. Günther, M. Bust, P. Lehnartz, A. Bosio, and R.J. Wiesner Isolation of functional pure mitochondria by superparamagnetic microbeads Anal. Biochem. 389 2009 1 5
112. M.R. Duchen Roles of mitochondria in health and disease Diabetes 53 2004 S96 S102
113. V. Salnikov, Y. Lukyánenko, C. Frederick, W. Lederer, and V. Lukyánenko Probing the outer mitochondrial membrane in cardiac mitochondria with nanoparticles Biophys. J. 92 2007 1058 1071
114. M.P. Schwartz, and A. Matouschek The dimensions of the protein import channels in the outer and inner mitochondrial membranes PNAS 96 1999 13086 13090
115. N. Pfanner, and K.N. Truscott Powering mitochondrial protein import Nat. Struct. Biol. 9 2002 234 236
116. A. Parfenov, V. Salnikov, W. Lederer, and V. Lukyánenko Aqueous diffusion pathways as a part of the ventricular cell ultrastructure Biophys. J. 90 2006 1107 1119
117. R.W. Horobin, S. Trapp, and V. Weissig Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria J. Control. Release 121 2007 125 136
118. E. Liberman, and V. Skulachev Conversion of biomembrane-produced energy into electric form. IV. General discussion Biochim. Biophys. Acta (BBA) - Bioenergetics 216 1970 30 42
119. K.L. Horton, K.M. Stewart, S.B. Fonseca, Q. Guo, and S.O. Kelley Mitochondria-penetrating peptides Chem. Biol. 15 2008 375 382
120. L.F. Yousif, K.M. Stewart, K.L. Horton, and S.O. Kelley Mitochondria-penetrating peptides: sequence effects and model cargo transport ChemBioChem 10 2009 2081 2088
121. V. Sebbage Cell-penetrating peptides and their therapeutic applications Biosci. Horizons 2 2009 64 72
122. J.P. Richard, K. Melikov, E. Vives, C. Ramos, B. Verbeure, M.J. Gait, L.V. Chernomordik, and B. Lebleu Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake J. Biol. Chem. 278 2002 585 590
123. A. Muratovska, R.N. Lightowlers, R.W. Taylor, J.A. Wilce, and M.P. Murphy Targeting large molecules to mitochondria Adv. Drug Deliv. Rev. 49 2001 189 198
124. V. Weissig, J. Lasch, G. Erdos, H.W. Meyer, T.C. Rowe, and J. Hughes DQAsomes: a novel potential drug and gene delivery system made from dequalinium Pharm. Res. 15 1998 334 337
125. Y.T. Ko, C. Falcao, and V.P. Torchilin Cationic liposomes loaded with proapoptotic peptide D-(KLAKLAK)(2) and Bcl-2 antisense oligodeoxynucleotide G3139 for enhanced anticancer therapy Mol. Pharm. 6 2009 971 977
126. Y. Yamada, H. Akita, H. Kamiya, K. Kogure, T. Yamamoto, Y. Shinohara, K. Yamashita, H. Kobayashi, H. Kikuchi, and H. Harashima MITO-Porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion Biochim. Biophys. Acta (BBA) - Biomembr. 1778 2008 423 432
127. S. Foley, C. Crowley, M. Smaihi, C. Bonfils, B.F. Erlanger, P. Seta, and C. Larroque Cellular localisation of a water-soluble fullerene derivative Biochem. Biophys. Res. Commun. 294 2002 116 119
128. S.V. Boddapati, P. Tongcharoensirikul, R.N. Hanson, G.G.M. D'Souza, V.P. Torchilin, and V. Weissig Mitochondriotropic liposomes J. Liposome Res. 15 2005 49 58
129. A. Hoshino, K. Fujioka, T. Oku, S. Nakamura, M. Suga, Y. Yamaguchi, K. Suzuki, M. Yasuhara, and K. Yamamoto Quantum dots targeted to the assigned organelle in living cells Microbiol. Immunol. 48 2004 985 994
130. D.C. Joshi, and J.C. Bakowska Determination of mitochondrial membrane potential and reactive oxygen species in live rat cortical neurons J. Viszual. Exp. 2011 1 4
131. D. Cassart, T. Fett, M. Sarlet, E. Baise, F. Coignoul, and D. Desmecht Flow cytometric probing of mitochondrial function in equine peripheral blood mononuclear cells BMC Vet. Res. 3 2007 1 7
132. M. Poot, and R.H. Pierce Analysis of mitochondria by flow cytometry Methods Cell Biol. 64 2001 117 128
133. G. Lamm, P. Steinlein, M. Cotten, and G. Christofori A rapid, quantitative and inexpensive method for detecting apoptosis by flow cytometry in transiently transfected cells Nucleic Acids Res. 25 1997 4855 4857
134. B.G. Poe, M. Navratil, and E.A. Arriaga Analysis of subcellular sized particles J. Chromatogr. A 1137 2006 249 255
135. T. Wakabayashi, M.A. Teranishi, M. Karbowski, Y. Nishizawa, J. Usukura, C. Kurono, and T. Soji Functional aspects of megamitochondria isolated from hydrazine- and ethanol-treated rat livers Pathol. Int. 50 2000 20 33
136. P. Petit, P. Diolez, P. Muller, and S.C. Brown Binding of concanavalin A to the outer membrane of potato tuber mitochondria detected by flow cytometry FEBS Lett. 196 1986 65 70
137. J.M. Medina, C. López-Mediavilla, and A. Orfao Flow cytometry of isolated mitochondria during development and under some pathological conditions FEBS Lett. 510 2002 127 132
138. P. Mukhopadhyay, M. Rajesh, K. Yoshihiro, G. Haskó, and P. Pacher Simple quantitative detection of mitochondrial superoxide production in live cells Biochem. Biophys. Res. Commun. 358 2007 203 208
139. R.A. Gottlieb, and D.J. Granville Analyzing mitochondrial changes during apoptosis Methods 26 2002 341 347
140. B.H. Kang, M.D. Siegelin, J. Plescia, C.M. Raskett, D.S. Garlick, T. Dohi, J.B. Lian, G.S. Stein, L.R. Languino, and D.C. Altieri Preclinical characterization of mitochondria-targeted small molecule Hsp90 inhibitors, gamitrinibs, in advanced prostate cancer Clin. Cancer Res. 16 2010 4779 4788
141. N. Zheng, H.N. Tsai, X. Zhang, and G.R. Rosania The subcellular distribution of small molecules: from pharmacokinetics to synthetic biology Mol. Pharmaceutics 8 2011 1619 1628
142. L. Cavelier, A. Johannisson, and U. Gyllensten Analysis of mtDNA copy number and composition of single mitochondrial particles using flow cytometry and PCR Exp. Cell Res. 259 2000 79 85
143. S. Meeusen, J.M. McCaffery, and J. Nunnari Mitochondrial fusion intermediates revealed in vitro Science 305 2004 1747 1752